Panel Luncheon Seminar #2
Credit Hours:1.75 CME/CMLE/SAM
Cytopathology Beyond Borders 2011: A Joint Panel Luncheon with the British Society for Clinical Cytology (BSCC)
Moderator: Dina R. Mody, MD
Panelists: Ashish Chandra, FRCPath, DipRCPath (Cytol)
Mina Desai, FRCPath, CBE
Manon Auger, MD, FRCP (C)
1. Analyze and contrast PAP test automation and HPV testing in the UK and USA and determine the direction of the cervical screening programs in the two countries
2. Review and compare the Bethesda System for reporting thyroid cytopathology (TBSRCT) and the corresponding RCPath terminology for a multidisciplinary approach
This is the first presentation under the title of “Cytopathology Beyond Borders,” where the ASC will present a panel luncheon jointly with another overseas Cytopathology society. The ASC is delighted to invite the BSCC to be the collaborator for 2011.
The 2011 presentation will consists of two separate segments:
The first segment will focus on a review of liquid-based cytology (LBC), Pap test automation and HPV testing in the four countries that make up the United Kingdom (UK), and analyze how each will determine the direction of its cervical screening program. The four nations of the United Kingdom: England, Scotland, Wales and Northern Ireland have adopted different pathways for the National Cervical Screening Program. The differences were minimal until recently. However, the gap is widening with the rapid implementation of new technologies in these programs. All four programs have tried to perform in-house validation of LBC, automation and HPV tests. The methods of these validation processes varied between the nations, which has brought different end results. This has led to very different screening pathways for the prevention of cervical cancer in the four nations of the United Kingdom. An summary update of the same topics involving North America will be presented for comparison.
The second segment of the program will discuss the thyroid reporting system as practiced in the two countries. The RCPath terminology for reporting thyroid FNA. In this recently proposed terminology, thyroid aspirates are reported with a conclusion in text format, accompanied by a numerical code (Thy 1-5). The numerical diagnostic categories closely parallel the Bethesda classification for reporting thyroid FNA. A study in the UK has addressed the question of interobserver variation between the diagnostic categories and its findings will be discussed. Increasing awareness and acceptance of the terminology is expected to improve uniformity in reporting practice. A review and update involving the Bethesda System for Reporting Thyroid Cytopathology (TBSRCT) will be presented as well. The discussions on both terminology systems will follow a multidisciplinary approach for a more meaningful impact.